Important Notice Regarding CSIR-UGC NET June 2017 Result
Important Notice Regarding CSIR-UGC NET June 2017 Result
Council of Scientific and Industrial Research
Human Resource Development Group
NOTICE
Re: Joint CSIR-UGC JRF/NET EXAM held on 18th June...
Drug Firms Urge PMO to Intervene, Act against Gelatine Capsule Replacement
Drug Firms Urge PMO to Intervene against Gelatine Capsule Replacement
The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare,...
Tandon Researcher Developing Potential Antidotes to Neutralize Chemical Weapons
Researcher Developing Antidotes to Neutralize Chemical Weapons
Among the Weapons of Mass Destruction (WMD), chemical warfare (CW) is probably one of the most brutal created...
Could Triple Protection Vaccine Spell the End of Pneumonia?
Could Triple Protection Vaccine Spell the End of Pneumonia?
Although the number of pneumonia-related deaths reduced by one million between 2004 and 2015 due to...
New Strain of China’s Saltwater Rice Boosts Country’s Rice Harvest by Nearly 20%, Can...
China’s Saltwater Rice Boosts Country’s Rice Harvest by Nearly 20%
Back in the 1970s, the godfather of rice, Yuan Longping was one of the first scientists...
Scientists Study the Third Type of Diabetes, Warn about Repercussions of Misdiagnosis
Scientists Study the Third Type of Diabetes-Repercussions of Misdiagnosis
Type 3c diabetes mellitus is more common than generally thought. Its prevalence is supposed to be...
Stanford’s I-O Spinout Forty Seven Bags $75M in Series B Financing
Stanford's I-O Spinout Forty Seven Bags $75M in Series B Financing
I-O company, Forty Seven Inc., has now closed $75 million Series B financing, bringing in...
Turning on the Gene “Circuit” Switch to Combat Cancer
Turning on the Gene “Circuit” Switch to Combat Cancer
Despite its success in several clinical trials, cancer immunotherapy remains limited by the rarity of targetable...
AstraZeneca Backed Swiss Cancer Biotech Completes $200M Funding Round
AstraZeneca Swiss Cancer Biotech Completes $200M Funding Round
Swiss cancer antibody-drug conjugate (ADC) developer ADC Therapeutics has now announced the close of its $200M mega...
IIT-M Rolls Out New Biotech Wing with State-of-Art Research Facilities
To note here is the first of its kind community-driven National Cancer Tissue Biobank, the animal house, and the Indo-German Sustainability Centre integrated into...
Biotecnika Times – Newsletter 25.10.2017
IOC-DBT-Deakin Fellowships - Applications Invited
Applications from Indian nationals for “IOC-DBT-Deakin Fellowships” to work in Biotechnology area are invited.............. Read More
ISRO - SAC Hiring | JRF Post...
CDMO Pfizer CentreOne Announces Launch of New Facility in Japan
CDMO Pfizer CentreOne Announces Launch of New Facility in Japan
Pfizer’s contract development and manufacturing organization are now all set to offer services in Nagoya,...
Scientists Validate a Biomarker Indicative of Glioblastoma Progression, Drug Response
Scientists Validate a Biomarker Indicative of Glioblastoma Progression
Glioblastoma is a highly aggressive and heterogeneous form of brain cancer, with a median survival time from...
Study Smokes out Gene That Turns Fungi into Pathogens
Study Smokes out Gene That Turns Fungi into Pathogens
A new investigation by scientists at the Rothamsted Research illuminates how the fungus causes disease in...
Visterra Tops Off Series C Financing with $46.7M
Visterra Therapeutics Tops Off Series C Financing with $ 46.7M
A clinical-stage biotechnology company, Visterra Therapeutics, has hauled a whopping $46.7 million in series C...


































